Prognostic impact of HNF4alpha expression in TTF-1-negative non-squamous NSCLC treated with immune checkpoint inhibitor. Iso H, Ariyasu R, Fujishima S, Ito M, et al. Lung Cancer 2025;205:108631.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Iso H, Ariyasu R, Fujishima S, Ito M, et al. Prognostic impact of HNF4alpha expression in TTF-1-negative non-squamous NSCLC treated with immune checkpoint inhibitor. Lung Cancer 2025;205:108631.
PMID: 40577985